Rubric Capital Management LP Halozyme Therapeutics, Inc. Transaction History

Rubric Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$16.87 - $20.3 $15.4 Million - $18.5 Million	-912,963 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$17.06 - $21.2 $6.44 Million - $8.01 Million	-377,694 Reduced 29.26%	912,963 $17.9 Million
Q4 2017 Feb 14, 2018	BUY	$16.75 - $20.8 $8.5 Million - $10.6 Million	507,657 Added 64.83%	1,290,657 $26.1 Million
Q3 2017 Nov 13, 2017	BUY	$11.76 - $17.4 $9.21 Million - $13.6 Million	783,000	783,000 $13.6 Million

542

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.35B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rubric Capital Management LP with notifications on news.